Literature DB >> 31008634

Examining race as a predictor and moderator of treatment outcomes for binge-eating disorder: Analysis of aggregated randomized controlled trials.

Janet A Lydecker1, Ralitza Gueorguieva1, Robin Masheb1, Marney A White1, Carlos M Grilo1.   

Abstract

OBJECTIVE: To examine whether race predicted or moderated response to treatments for binge-eating disorder (BED).
METHOD: Participants were 592 adults (n = 113 Black; n = 479 White) with DSM-IV-defined BED who participated in randomized controlled trials (RCTs) at 1 medical center. Data were aggregated from RCTs for BED testing cognitive-behavioral therapy, behavioral weight loss, multimodal treatment, and/or control conditions. Participants had weight and height measured and were assessed using established interviews and self-report measures at baseline, throughout treatment, and post treatment.
RESULTS: Race did not significantly moderate treatment outcomes. Mixed models revealed a main effect of race: Black participants had fewer binge-eating episodes and lower depression than White participants across time points. Race also had a main effect in generalized estimating equations with a significantly greater proportion of Black participants achieving binge-eating remission than White participants. Race did not predict percent weight loss, but a significantly lower proportion of Black participants attained 5% weight loss than White participants. Race did not significantly predict global eating-disorder severity.
CONCLUSION: Despite disparities in treatment-seeking reported in epidemiological and RCT studies, Black individuals appear to have comparable or better treatment outcomes in BED treatment research compared with White individuals, except they were less likely to attain 5% weight loss at post treatment. This suggests that disseminating evidence-based treatments for BED among diverse populations holds promise and treatments may not require further adaptation prior to dissemination. Implementation research is needed to test treatment effectiveness across diverse providers, settings, and patient groups to improve understanding of potential predictors and moderators. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Entities:  

Mesh:

Year:  2019        PMID: 31008634      PMCID: PMC6589831          DOI: 10.1037/ccp0000404

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  40 in total

Review 1.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

2.  Different methods for assessing the features of eating disorders in patients with binge eating disorder: a replication.

Authors:  C M Grilo; R M Masheb; G T Wilson
Journal:  Obes Res       Date:  2001-07

3.  Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.

Authors:  V Ricca; E Mannucci; B Mezzani; S Moretti; M Di Bernardo; M Bertelli; C M Rotella; C Faravelli
Journal:  Psychother Psychosom       Date:  2001 Nov-Dec       Impact factor: 17.659

4.  A comparison of different methods for assessing the features of eating disorders in patients with binge eating disorder.

Authors:  C M Grilo; R M Masheb; G T Wilson
Journal:  J Consult Clin Psychol       Date:  2001-04

5.  Treatment preferences of patients with binge eating disorder.

Authors:  Michelle L Brody; Robin M Masheb; Carlos M Grilo
Journal:  Int J Eat Disord       Date:  2005-05       Impact factor: 4.861

6.  Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison.

Authors:  Carlos M Grilo; Robin M Masheb; G Terence Wilson
Journal:  Biol Psychiatry       Date:  2005-02-01       Impact factor: 13.382

Review 7.  Beneficial health effects of modest weight loss.

Authors:  D J Goldstein
Journal:  Int J Obes Relat Metab Disord       Date:  1992-06

8.  A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

Authors:  Jose C Appolinario; Josué Bacaltchuk; Rosely Sichieri; Angelica M Claudino; Amelio Godoy-Matos; Christina Morgan; Maria T Zanella; Walmir Coutinho
Journal:  Arch Gen Psychiatry       Date:  2003-11

9.  A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder.

Authors:  Denise E Wilfley; R Robinson Welch; Richard I Stein; Emily Borman Spurrell; Lisa R Cohen; Brian E Saelens; Jennifer Zoler Dounchis; Mary Ann Frank; Claire V Wiseman; Georg E Matt
Journal:  Arch Gen Psychiatry       Date:  2002-08

Review 10.  Binge eating disorder and obesity in 2003: could treating an eating disorder have a positive effect on the obesity epidemic?

Authors:  Susan Z Yanovski
Journal:  Int J Eat Disord       Date:  2003       Impact factor: 4.861

View more
  6 in total

1.  Binge eating and binge-eating disorder in Black women: A systematic review.

Authors:  Rachel W Goode; Mariah M Cowell; Suzanne E Mazzeo; Courtney Cooper-Lewter; Alexandria Forte; Oona-Ifé Olayia; Cynthia M Bulik
Journal:  Int J Eat Disord       Date:  2020-01-10       Impact factor: 4.861

2.  Ethnic and racial comparisons of weight-loss treatment utilization history and outcomes in patients with obesity and binge-eating disorder.

Authors:  Jaime A Coffino; Valentina Ivezaj; Rachel D Barnes; Marney A White; Brian P Pittman; Carlos M Grilo
Journal:  Eat Behav       Date:  2022-01-11

Review 3.  Loss-of-Control Eating and Cardiometabolic Health in Relation to Overweight and Obesity.

Authors:  Lisa M Shank; Nasreen A Moursi; Marian Tanofsky-Kraff
Journal:  Curr Diab Rep       Date:  2022-04-11       Impact factor: 4.810

4.  Clinical moderators and predictors of cognitive-behavioral therapy by guided-self-help versus therapist-led for binge-eating disorder: Analysis of aggregated clinical trials.

Authors:  Carlos M Grilo; Heather Thompson-Brenner; Rebecca M Shingleton; Douglas R Thompson; Debra L Franko
Journal:  Int J Eat Disord       Date:  2021-09-02       Impact factor: 5.791

5.  Analysis of Age, Race, Ethnicity, and Sex of Participants in Clinical Trials Focused on Eating Disorders.

Authors:  Laura E Flores; Roshell Muir; Imani Weeks; Helen Burton Murray; Julie K Silver
Journal:  JAMA Netw Open       Date:  2022-02-01

6.  Randomized Controlled Trial of Treatments for Loss-of-Control Eating Following Bariatric Surgery.

Authors:  Carlos M Grilo; Valentina Ivezaj; Andrew J Duffy; Ralitza Gueorguieva
Journal:  Obesity (Silver Spring)       Date:  2021-03-10       Impact factor: 5.002

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.